These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2937012)

  • 1. Lymphocyte markers in patients with progressive systemic sclerosis.
    Czirják L; Dankó K; Sonkoly I; Bodolay E; Szegedi G
    Acta Med Hung; 1985; 42(3-4):109-14. PubMed ID: 2937012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T lymphocyte subpopulations in progressive systemic sclerosis defined by monoclonal antibodies.
    Czirják L; Surányi P; Dankó K; Szegedi G
    Acta Med Hung; 1985; 42(3-4):129-32. PubMed ID: 3879347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and cellular immunity in progressive systemic sclerosis.
    Sierakowski S; Bernacka K
    Med Interne; 1987; 25(4):233-8. PubMed ID: 3501150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subpopulations of human T lymphocytes. IX. Imbalance of T cell subpopulations in patients with progressive systemic sclerosis.
    Gupta S; Malaviya AN; Rajagopalan P; Good RA
    Clin Exp Immunol; 1979 Nov; 38(2):342-7. PubMed ID: 316754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human postthymic precursor cells in health and disease. VII. Immunoregulatory circuits of the peripheral blood mononuclear cells from patients with progressive systemic sclerosis.
    Alarcón-Segovia D; Palacios R; Ibáñez de Kasep G
    J Clin Lab Immunol; 1981 May; 5(3):143-8. PubMed ID: 6453999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte subpopulations and reactivity to mitogens in patients with scleroderma.
    Baron M; Keystone EC; Gladman DD; Lee P; Poplonski L
    Clin Exp Immunol; 1981 Oct; 46(1):70-6. PubMed ID: 6978216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced circulating natural killer T cells and gamma/delta T cells in patients with systemic sclerosis.
    Riccieri V; Parisi G; Spadaro A; Scrivo R; Barone F; Moretti T; Bernardini G; Strom R; Taccari E; Valesini G
    J Rheumatol; 2005 Feb; 32(2):283-6. PubMed ID: 15693088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization with monoclonal antibodies of T lymphocytes bearing Fc receptors for IgE (T epsilon cells) and IgG (T gamma cells) in atopic patients.
    Thompson LF; Mellon MH; Zeiger RS; Spiegelberg HL
    J Immunol; 1983 Dec; 131(6):2772-6. PubMed ID: 6227666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal values and membrane markers of theophylline-sensitive and theophylline-resistant human T-lymphocytes.
    Kaden J; Samietz C; Kaden K; Groth J; Grunow R; Volk HD
    Allerg Immunol (Leipz); 1986; 32(1):27-32. PubMed ID: 2940848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular immunity in pregnancy: subpopulations of T lymphocytes bearing Fc receptors for IgG and IgM in pregnant women.
    Hirahara F; Gorai I; Tanaka K; Matsuzaki Y; Sumiyoshi Y; Shiojima Y
    Clin Exp Immunol; 1980 Aug; 41(2):353-7. PubMed ID: 6969153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies of the role of cellular immunity and angiogenetic changes in the pathogenesis of circumscribed scleroderma].
    Majewski S; Błaszczyk M; Chibowska M; Rosińska-Borkowska D; Kencka D; Rudnicka L; Marczak M; Makieła B; Skiendzielewska A; Jabłońska S
    Przegl Dermatol; 1990; 77(4):249-51. PubMed ID: 2267352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface markers for characterisation of bovine blood lymphocyte populations and changes in these from birth to maturity.
    Outteridge PM; Dufty JH
    Res Vet Sci; 1981 Nov; 31(3):315-22. PubMed ID: 6210941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating T and B lymphocytes in progressive systemic sclerosis.
    de Jesus DG; Clancy RL
    J Rheumatol; 1975 Sep; 2(3):336-9. PubMed ID: 1081143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities of T lymphocyte subsets in patients with progressive systemic sclerosis (PSS, scleroderma).
    Inoshita T; Whiteside TL; Rodnan GP; Taylor FH
    J Lab Clin Med; 1981 Feb; 97(2):264-77. PubMed ID: 6450255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Receptor activity of T lymphocytes in patients with atopic dermatitis].
    Dynowska D; Sanokowska E
    Przegl Lek; 1995; 52(6):303-6. PubMed ID: 7568984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of defective cell-mediated immunity to visceral disease in systemic sclerosis.
    Hughes P; Holt S; Rowell NR; Allonby ID; Janis K; Dodd JK
    Clin Exp Immunol; 1977 May; 28(2):233-40. PubMed ID: 301448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [T-lymphocyte values in peripheral blood in systemic lupus erythematosus and similar nosological entities (progressive systemic sclerosis, rheumatoid arthritis, and mixed connective tissue disease) (author's transl)].
    Rovenský J; Jarosková L; Zitnan D; Pekábek J; Svejcar J
    Cas Lek Cesk; 1982 Mar; 121(12):370-4. PubMed ID: 6979391
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of T-lymphocyte subpopulations in juvenile-onset diabetics.
    Müller R; Kolb H; Kuschak D; Jörgens V; Gries FA
    Clin Exp Immunol; 1980 Jan; 39(1):130-5. PubMed ID: 6966986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of plasmapheresis on cellular immunity abnormalities in patients with systemic lupus erythematosus.
    Bonomini V; Vangelista A; Frascà GM; Nanni-Costa A; Borgnino LC
    Clin Nephrol; 1984 Sep; 22(3):121-6. PubMed ID: 6237815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-dependent cellular cytotoxicity mediated by subpopulations of human T lymphocytes: killing of human erythrocytes and autologous lymphoid cells.
    Katz P; Fauci AS
    Immunology; 1980 Mar; 39(3):407-16. PubMed ID: 6969215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.